☆ 4.7 Article

COVID-19 associated bacterial infections in intensive care unit: a case control study

SCIENTIFIC REPORTS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Immunology

Immune-Based Therapy for Hospitalized Patients With COVID-19 and Risk of Secondary Infections: A Systematic Review and Meta-analysis

Dima Kabbani et al.

Summary: This study aimed to evaluate whether immune-based therapies increase the risk of secondary infections in COVID-19 hospitalized patients. A meta-analysis of 37 RCTs showed that immune-based therapy had a mild protective effect on the occurrence of secondary infections, and it was not influenced by age, sex, or mechanical ventilation.

OPEN FORUM INFECTIOUS DISEASES (2023)

添加到收藏夹

Review Infectious Diseases

Effectiveness of tocilizumab in non-intubated cases with COVID-19: a systematic review and meta-analysis

Siran Keske et al.

Summary: This study found that tocilizumab reduces the risk of invasive mechanical ventilation and mortality in non-intubated severe COVID-19 cases compared to standard-of-care treatment.

INFECTION (2023)

添加到收藏夹

Article Medicine, General & Internal

Secondary Infections in Critical Patients with COVID-19 Associated ARDS in the ICU: Frequency, Microbiologic Characteristics and Risk Factors

Muhammet Ridvan Taysi et al.

Summary: This study aimed to determine the frequency, microbiologic characteristics, and risks of secondary infections in patients with COVID-19 associated ARDS. The results showed a high rate of secondary infections in these patients, and it is important to reduce the duration of mechanical ventilation and ICU stay, as well as remove invasive catheters as soon as possible to prevent secondary infections.

JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN (2023)

添加到收藏夹

Article Infectious Diseases

Elimination of healthcare-associated Acinetobacter baumannii infection in a highly endemic region

Onder Ergonul et al.

Summary: This paper describes the elimination of healthcare-associated Acinetobacter baumannii infections in a highly endemic region. The control of Acinetobacter baumannii outbreaks can be achieved by close follow-up supported by molecular techniques, strict application of infection control measures, and isolation of transferred patients.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Critical Care Medicine

Trends in ICU Mortality From Coronavirus Disease 2019: A Tale of Three Surges

Sara C. Auld et al.

Summary: This study aims to explore the association between time period of hospitalization and hospital mortality among critically ill adults with coronavirus disease 2019. The study found that the risk of death was highest for patients admitted during the fall and winter of 2020. Hospital mortality was associated with preexisting risk factors, clinical status at ICU admission, and ICU interventions.

CRITICAL CARE MEDICINE (2022)

添加到收藏夹

Article Infectious Diseases

Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting

Burcu Isler et al.

Summary: This study investigated carbapenem-resistant Klebsiella spp. bloodstream infections in Turkey and found important findings such as the prevalence of different types of carbapenemases and factors associated with mortality rates.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Infectious Diseases

Corticosteroids and superinfections in COVID-19 patients on invasive mechanical ventilation

Signe Sovik et al.

Summary: Dexamethasone use in mechanically ventilated COVID-19 patients is strongly associated with superinfections, as well as pre-existing autoimmune disease and longer ICU stays. While superinfections do not impact 90-day survival, patients receiving dexamethasone have lower survival rates.

JOURNAL OF INFECTION (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods — United States, April 2020–June 2022

Stacey Adjei et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Characteristics and mortality of 561,379 hospitalized COVID-19 patients in Germany until December 2021 based on real-life data

Jan Andreas Kloka et al.

Summary: This study analyzed the hospitalization and ICU status of COVID-19 patients in Germany and found that 24.54% of hospitalized patients required ICU treatment, with a 33.36% mortality rate among ICU patients. The study also found that lower grades of obesity may have a protective effect on patient survival, while congestive heart failure was associated with a higher risk of death.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Infectious Diseases

Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study

Carolina Garcia-Vidal et al.

Summary: The study found that co-infections and superinfections in hospitalized COVID-19 patients were relatively low compared to other viral pandemics. Patients experienced worse outcomes after hospital-acquired superinfections occurred.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Article Infectious Diseases

Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome

Tommaso Bardi et al.

Summary: Co-infection of bacteria and fungi is common in ICU-admitted COVID-19 patients and usually presents as a severe form of infection, associated with a high mortality rate and longer ICU stay.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Infectious Diseases

Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis

Imad M. Tleyjeh et al.

Summary: This study reviewed the efficacy of the IL-6 receptor antagonist tocilizumab in COVID-19 patients. The results showed that tocilizumab can reduce the risk of mechanical ventilation, but its impact on short-term mortality remains inconclusive. Additionally, the use of tocilizumab does not increase the risk of infections or adverse events.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Article Medicine, General & Internal

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani et al.

LANCET (2021)

添加到收藏夹

Article Multidisciplinary Sciences

ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida

Eduardo Oliveira et al.

Summary: Our study in the largest healthcare system in Florida described the clinical characteristics and outcomes of severe COVID-19 patients admitted to ICU. The study showed that survivors of severe COVID-19 had longer durations of mechanical ventilation, hospital stay, and ICU stay compared to non-survivors.

PLOS ONE (2021)

添加到收藏夹

Review Infectious Diseases

Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients

Zelalem G. Dessie et al.

Summary: Chronic comorbidities, complications, and demographic factors such as acute kidney injury, COPD, diabetes, hypertension, CVD, cancer, increased D-dimer, male gender, older age, current smoker, and obesity are identified as clinical risk factors for fatal outcomes related to coronavirus mortality, according to large dataset from 42 studies involving 423,117 patients. The findings provide valuable insights for future research, control, and prevention of the disease.

BMC INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients

Nurdan Kokturk et al.

Summary: This study retrospectively evaluated 1500 adults with COVID-19 in Turkey and found that male sex, age >= 65 years, dyspnea or confusion, malignancy, chronic obstructive lung disease, interstitial lung disease, immunosuppressive conditions, severe pneumonia, multiorgan dysfunction, and sepsis were positively associated with mortality.

RESPIRATORY MEDICINE (2021)

添加到收藏夹

Article Immunology

Hospital-Acquired Bloodstream Infections in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019): Association With Immunosuppressive Therapies

Akshay Khatri et al.

Summary: Combination immunosuppressive therapies were significantly associated with the occurrence of bloodstream infections in COVID-19 patients, calling for increased surveillance of infections. Further studies are needed to establish their causative role in these infections.

OPEN FORUM INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Health Care Sciences & Services

Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study

Raquel Carbonell et al.

Summary: The study found that despite significant changes in treatment and supportive care between COVID-19 waves, there was no significant improvement in case fatality rates among critical COVID-19 pneumonia patients. The proportion of patients using high flow nasal cannula and corticosteroids significantly increased in the second/third waves, while ventilator-associated pneumonia rate rose. A significant reduction in ICU and hospital length of stay was observed in survivors during the second/third waves.

LANCET REGIONAL HEALTH-EUROPE (2021)

添加到收藏夹

Article Critical Care Medicine

Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study

Matthieu Schmidt et al.

Summary: Among more than 4000 critically ill patients with COVID-19 admitted to our ICUs, 90-day mortality was 31% and decreased from 42 to 25% over the study period. Mortality was higher in older, diabetic, obese and severe ARDS patients.

INTENSIVE CARE MEDICINE (2021)

添加到收藏夹

Article Immunology

Hospital-Acquired Bloodstream Infections in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019): Association With Immunosuppressive Therapies

Akshay Khatri et al.

Summary: This study retrospectively assessed the association between immunosuppressive therapies and bloodstream infections in hospitalized COVID-19 patients, finding that the combination of corticosteroid-tocilizumab therapy was significantly associated with BSIs. Further studies are needed to establish causation.

OPEN FORUM INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Medicine, General & Internal

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou et al.

LANCET (2020)

添加到收藏夹

Review Infectious Diseases

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

Bradley J. Langford et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

添加到收藏夹

Article Infectious Diseases

Appropriate use of tocilizumab in COVID-19 infection

Siran Keske et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Infectious Diseases

Community-acquired bacterial co-infection predicts severity and mortality in influenza-associated pneumonia admitted patients

Fei Teng et al.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2019)

添加到收藏夹

Article Critical Care Medicine

DEVELOPING A NEW, NATIONAL APPROACH TO SURVEILLANCE FOR VENTILATOR-ASSOCIATED EVENTS

Shelley S. Magill et al.

AMERICAN JOURNAL OF CRITICAL CARE (2013)

添加到收藏夹

Editorial Material Immunology

Guidelines for the Prevention of Intravascular Catheter-related Infections

Naomi P. O'Grady et al.

CLINICAL INFECTIOUS DISEASES (2011)

添加到收藏夹

Editorial Material Public, Environmental & Occupational Health

Guideline for Prevention of Catheter-Associated Urinary Tract Infections 2009

Carolyn V. Gould et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.